World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
79
Citations
21288
World Ranking
1221
National Ranking
546

Michael E. Pichichero publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Michael E. Pichichero sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 449 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Michael E. Pichichero D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael E. Pichichero sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 79 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Michael E. Pichichero is affiliated with Rochester Regional Health in the United States and has contributed extensively to research in medicine, immunology, and microbiology. Their work primarily focuses on epidemiology, microbiology, immunology, otorhinolaryngology, and pulmonary and respiratory medicine.

The main topics covered in their research include:

  • Pneumonia and Respiratory Infections
  • Bacterial Infections and Vaccines
  • Respiratory Viral Infections Research
  • Ear Surgery and Otitis Media
  • Influenza Virus Research Studies
  • Respiratory and Cough-Related Research
  • Pneumocystis jirovecii Pneumonia Detection and Treatment

Michael E. Pichichero has published numerous papers in prominent journals. Notable recent works include:

  • "Rising Pneumococcal Antibiotic Resistance in the Post-13-Valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates From a Primary Care Setting," 2020, Clinical Infectious Diseases
  • "Interferon-γ promotes monocyte-mediated lung injury during influenza infection," 2022, Cell Reports
  • "Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015-2019," 2021, European Journal of Clinical Microbiology & Infectious Diseases
  • "COVID-19 Pandemic Impact on Respiratory Infectious Diseases in Primary Care Practice in Children," 2021, Frontiers in Pediatrics
  • "Immunologic dysfunction contributes to the otitis prone condition," 2020, Journal of Infection

The scientist frequently collaborates with:

  • Ravinder Kaur
  • Naoko Fuji
  • Minh Tuan Pham
  • Peter Bajorski
  • Eduardo González

Michael E. Pichichero's work is regularly published in journals such as:

  • Vaccine
  • The Pediatric Infectious Disease Journal
  • The Journal of Infectious Diseases
  • PEDIATRICS
  • Journal of Biological Chemistry

Best Publications

  • Changes in frequency and pathogens causing acute otitis media in 1995-2003

    Janet R Casey;Michael E Pichichero

  • Immune responses in neonates

    Unknown

  • Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in Children

    Michael E. Pichichero;Janet R. Casey

  • New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

    Janet R. Casey;Diana G. Adlowitz;Michael E. Pichichero

  • Safety and Efficacy of High-dose Rhesus-Human Reassortant Rotavirus Vaccines—Report of the National Multicenter Trial

    Margaret B. Rennels;Roger I. Glass;Penelope H. Dennehy;David I. Bernstein

  • Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS).

    Marie Lynd Murphy;Michael E. Pichichero

  • Comparison of 13 Acellular Pertussis Vaccines: Overview and Serologic Response

    Kathryn M. Edwards;Bruce D. Meade;Michael D. Decker;George F. Reed

  • Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era

    Unknown

  • Comparison of 13 Acellular Pertussis Vaccines: Adverse Reactions

    Michael D. Decker;Kathryn M. Edwards;Mark C. Steinhoff;Margaret B. Rennels

  • Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study

    Michael E Pichichero;Elsa Cernichiari;Joseph Lopreiato;John Treanor

  • Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.

    David J. Farrell;Keith P. Klugman;Michael Pichichero

  • Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US Children

    David I. Bernstein;Roger I. Glass;George Rodgers;Bruce L. Davidson

  • Protein carriers of conjugate vaccines

    Unknown

  • The Effect of Maternal Antibody on the Serologic Response and the Incidence of Adverse Reactions After Primary Immunization With Acellular and Whole-Cell Pertussis Vaccines Combined with Diphtheria and Tetanus Toxoids

    Janet A. Englund;Edwin L. Anderson;George F. Reed;Michael D. Decker

  • The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.

    H F. Clark;P. A. Offit;R. W. Ellis;J. J. Eiden

  • A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity.

    Michael E. Pichichero;Peter A. Margolis

  • Children With Influenza A Infection: Treatment With Rimantadine

    C B Hall;R Dolin;C L Gala;D M Markovitz

  • Cross-reactivity in β-Lactam Allergy.

    Unknown

  • Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.

    Margaret B. Rennels;Maria A. Deloria;Michael E. Pichichero;Genevieve A. Losonsky

  • Zanamivir Prophylaxis: An Effective Strategy for the Prevention of Influenza Types A and B within Households

    Arnold S. Monto;Michael E. Pichichero;Steve J. Blanckenberg;Olli Ruuskanen

  • Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.

    P W Anderson;M E Pichichero;R A Insel;R Betts

  • Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.

    Michael E. Pichichero;Margaret B. Rennels;Kathryn M. Edwards;Mark M. Blatter

  • Adverse and beneficial effects of immediate treatment of Group A beta-hemolytic streptococcal pharyngitis with penicillin.

    Michael E. Pichichero;Frank A. Disney;William B. Talpey;John L. Green

  • Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

    H.Fred Clark;David I Bernstein;Penelope H Dennehy;Paul Offit

  • A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.

    Michael E. Pichichero;Maria A. Deloria;Margaret B. Rennels;Edwin L. Anderson

  • Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis

    Michael E. Pichichero;Robert Cohen

  • Persistent acute otitis media: I. Causative pathogens.

    Michael E. Pichichero;Christy L. Pichichero

  • Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.

    M A Shelly;H Jacoby;G J Riley;B T Graves

Frequent Co-Authors

John J. Treanor
John J. Treanor University of Rochester Medical Center
Richard A. Insel
Richard A. Insel University of Rochester Medical Center
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center
Janet A. Englund
Janet A. Englund Seattle Children's Hospital
Mark C. Steinhoff
Mark C. Steinhoff Cincinnati Children's Hospital Medical Center
Genevieve Losonsky
Genevieve Losonsky University of Maryland, Baltimore
Keith S. Reisinger
Keith S. Reisinger University of Rochester
David I. Bernstein
David I. Bernstein University of Cincinnati
Ron Dagan
Ron Dagan Ben-Gurion University of the Negev
Paul A. Offit
Paul A. Offit Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, expanding your career options through related online degrees can be a strategic move. Programs like cahiim accredited health information management programs online offer a blend of healthcare knowledge and information management skills. These are ideal for individuals aiming to work behind the scenes in medical records and data management.

If you’re looking for quicker certifications, exploring the fastest online medical billing and coding certificate programs can pave the way to entry-level roles in healthcare administration, bridging the gap between microbiology and healthcare services.

For those considering a broader healthcare perspective, numerous online healthcare degrees provide flexible options. These degrees can complement a microbiology background and enhance prospects in clinical and research settings.

Lastly, public health is an excellent complementary field, with some of the best easiest mph online programs to get into offering accessible pathways for microbiologists aiming to impact population health and epidemiology effectively.

Best Scientists Citing Michael E. Pichichero

Trending Scientists

Recently Published Articles